Mar 26, 2020
2020 Synovial Sarcoma (Oncology) Pipeline Guide
Mar 24, 2020
Kaposi Sarcoma Pipeline Report, H1 2020 - Analysis by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type
Mar 03, 2020
Rothman Orthopaedics Surgeon Specializing in Rare Bone and Soft Tissue Cancers to Lead Capital Health's Sarcoma and Orthopaedic Oncology Program
Jan 30, 2020
Soft Tissue Sarcoma Market Size is Expected to Increase With a CAGR of 6.47% During Study Period for 7MM as per DelveInsight's Analysis
Jan 23, 2020
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
Oct 14, 2019
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal
Jul 15, 2019
Onkos Surgical® and The Sarcoma Foundation of America to Sponsor Upcoming Cancer Awareness Fundraiser
Jul 02, 2019
Monopar Therapeutics and the Spanish Sarcoma Group (GEIS) Team Up on Phase 2 Sarcoma Trial With Monopar's Novel Camsirubicin
Jan 18, 2019
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO®
Jan 09, 2019
Ken Pribil Jr. Foundation Supports Angiosarcoma Research at Memorial Sloan Kettering Cancer Center
Nov 27, 2018
Eisai to Present New Research on HALAVEN® (eribulin mesylate) Injection at 41st Annual San Antonio Breast Cancer Symposium
Nov 21, 2018
Ladies Meet on LinkedIn & Share a Lasting Legacy of Gratitude on Behalf of The Josh Powell Foundation
Nov 06, 2018
St. Baldrick's Foundation and Osteosarcoma Collaborative Partner to Fund Lifesaving Childhood Cancer Research
Nov 01, 2018
Global Sarcoma Drugs Market, 2017-2023 - New Product Launches, Increasing Adoption of Novel Therapeutics, and Growing Target Population
Oct 25, 2018
ELIAS Animal Health Announces Positive Results in Treatment of Osteosarcoma in Dogs
Sep 25, 2018
American Academy of Orthopaedic Surgeons endorses the Musculoskeletal Tumor Society's appropriate use criteria that informs doctors' monitoring of bone and soft tissue sarcoma survivors
Sep 24, 2018
Sarcoma Drugs Market Size Worth $1.2 Billion by 2023 | CAGR: 8.5%: Grand View Research, Inc.
Jun 21, 2018
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
Jun 21, 2018
CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology
May 30, 2018
Polaris Group Announces Treatment of First Patient in a Phase 2 Study of ADI-PEG 20 Plus Gemcitabine and Docetaxel for Soft Tissue Sarcoma